FUCOIDAN FROM BROWN ALGAE FUCUS EVANESCENS: NEW PERSPECTIVES IN THE TREATMENT OF ATHEROSCLEROSIS
https://doi.org/10.17650/1726-9784-2017-16-1-82-87
Abstract
Objective. The purpose of the research is the experimental study of the possibility of correction of disorders of lipid metabolism, lipid peroxidation and antioxidant protection (POL-AOP), liver structure on the model of alimentary hyperlipidemia in mice. Materials and methods. Fucoidan, a sulfated polysaccharide with a molecular weight of 160 kDa, derived from brown algae Fucus evanescens. The alimentary hyperlipidemia model was reproduced in mice. The biochemical parameters of lipid metabolism, state of POL-AOP system and the liver structure by MRT were studied. Results. We revealed the ability of fucoidan at per os administration to animals to normalize the key parameters of lipid metabolism, indicators of POL-AOP system, liver anatomic-topographic structure. Conclusion. The ability of fucoidan to correct these parameters allows us to consider it as a basis for the development of new biological medicines for the treatment of atherosclerotic disorders.
About the Authors
S. P. Krizshanovsky
Medical Association of Far East Branch of Russian Academy of Science
Russian Federation
Russian Federation
T. A. Kuznetsova
G.P. Somov Research Institute of Epidemiology and Microbiology; Far Eastern Federal University, School of Biomedicine
Russian Federation
Russian Federation
B. I. Geltser
Far Eastern Federal University, School of Biomedicine
Russian Federation
Russian Federation
T. S. Zaporozhets
Medical Association of Far East Branch of Russian Academy of Science; G.P. Somov Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
S. P. Ermakova
G.B. Elyakov Pacific Institute of Bioorganic Chemistry
Russian Federation
Russian Federation
N. N. Besednova
G.P. Somov Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
References
1. Бобрышев Ю.В. Клеточные механизмы атеросклероза: врожденный иммунитет и воспаление. Фундаментальные науки и практика 2010; 1(4): 54-9.
2. Anogeianaki A., Angelucci D., Cianchetti E. et al. Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol 2011; 24(4): 817-25. PMID: 22230389.
3. Fitton J.H., Stringer D.N., Karpiniec S.S. Therapies from fucoidan: an update. Mar Drugs 2015; 13: 5920-46. DOI: 10.3390/md13095920. PMID: 26389927.
4. Jiao G., Yu G., Zhang J., Ewart H.S. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar Drugs 2011; 9: 196-223. DOI: 10.3390/md9020196. PMID: 21566795.
5. Raposo M.FJ., Morais A.M.M.B., Morais R.M.S.C. Marine polysaccharides from algae with potential biomedical applications. Mar Drugs 2015; 13(5): 2967-3028. DOI: 10.3390/md13052967. PMID: 25988519.
6. Anastyuk S.D., Shevchenko N.M., Dmitrenok P.S., Zvyagintseva T.N. Structural similarities of fucoidans from brown algae Silvetia babingtonii and Fucus evanescens, determined by tandem MALDI-TOF mass spectrometry. Carbohydr Res 2012; 358: 78-81. DOI: 10.1016/j.carres.2012.06.015. PMID: 22824505.
7. Li D.Y., Xu Z., Huang L.M. et al. Effect of fucoidan of L. japonica on rats with hyperlipidemia. Food Sci 2001; 22: 92-5.
8. Park M.K., Jung U., Roh C. Fucoidan from marine brown algae inhibits lipid accumulation. Mar Drugs 2011; 9: 1359-67. DOI: 10.3390/md9081359. PMID: 21892350.
9. Kim K.J., Lee O.H., Lee B.Y. Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes. Life Sci 2010; 22: 791-7. DOI: 10.1016/j.lfs. PMID: 20346961.
10. Chen A.F., Chen D.D., Daiber A. et al. Free radical biology of the cardiovascular system. Clinic Sci 2012; 123(2): 73-91. DOI: 10.1042/CS20110562. PMID: 22455351.
11. Hu T., Liu D., Chen Y. et al. Antioxidant activity of sulfated polysaccharide fractions extracted from Undaria pinnitafida in vitro. Int J Biol Macromolecules 2010; 46(2): 193-8. DOI: 10.1016/j.ijbiomac. PMID: 20025899.
12. Hwang P., Wu C.H., Gau S.Y. et al. Antioxidant and immune-stimulating activities of hot-water extract from seaweed Sargassum hemiphyllum. J Marine Sci Technology 2010; 18(1): 41-6.
13. Imbs T.I., Skriptsova A.V., Zvyagintseva T.N. Antioxidant activity of fucoise-containing sulfated polysaccharides obtained from Fucus evanescens by different extraction methods. J Appl Phycol 2015; 27(1): 545-53. DOI: 10.1007/s10811 -014-0293-7.
14. Kim S., Choi D.S., Jeon T.J. et al. Antioxidant activity of sulfated polysaccharides isolated from Sargassum fulvellum. JFSN 2007; 12(2): 65-73. DOI: 10.3746/jfn.2007.12.2.065.
15. Беседнова Н.Н., Запорожец Т.С., Макаренкова И.Д. и др. Противовоспалительные эффекты сульфатированных полисахаридов из морских бурых водорослей. Успехи современной биологии 2012; 132(3): 312-20.
16. Майстровский К.В., Запорожец Т.С., Федянина Л.Н. и др. Влияние иммуномодулятора фукоидана из бурых водорослей Fucus evanescens на показатели антиоксидантной системы, липидного и углеводного обмена у мышей. Тихоокеанский медицинский журнал 2009; 3: 103-5.
17. Кузнецова Т.А., Агафонова И.Г., Крохмаль Т.С. и др. Гепатопротекторные свойства фукоидана из бурой водоросли Fucus evanescens. Тихоокеанский медицинский журнал 2010; 4: 26-9.
18. Kuznetsova T.A., Besednova N.N., Somova L.M., Plekhova N.G. Fucoidan extracted from Fucus evanescens prevents endotoxin-induced damage in a mouse model of endotoxemia. Mar Drugs 2014; 12: 886-98. DOI: 10.3390/md12020886/ PMID: 24492521.
19. Алексеенко Т.В., Жанаева С.Я., Венедиктова А.А. и др. Противоопухолевая и антиметастатическая активность сульфатированного полисахарида фукоидана, выделенного из бурой водоросли Охотского моря Fucus evanescens. Бюллетень экспериментальной биологии и медицины 2007; 143(6): 675-7.
20. Menshova R.V., Shevchenko N.M., Imbs T.I. Fucoidans from brown alga Fucus evanescens: structure and biological activity. Fron Mar Sci 2016; 3: 1-9. DOI: 10.3389/fmars.2016.00129.
Review
For citations:
Krizshanovsky S.P., Kuznetsova T.A., Geltser B.I., Zaporozhets T.S., Ermakova S.P., Besednova N.N. FUCOIDAN FROM BROWN ALGAE FUCUS EVANESCENS: NEW PERSPECTIVES IN THE TREATMENT OF ATHEROSCLEROSIS. Russian Journal of Biotherapy. 2017;16(1):82-87. (In Russ.) https://doi.org/10.17650/1726-9784-2017-16-1-82-87
Views:
627
Email this article 
